Novo Integrated Sciences Ventures into Global Protein Market
Company Announcements

Novo Integrated Sciences Ventures into Global Protein Market

Novo Integrated Sciences (NVOS) has shared an announcement.

Novo Integrated Sciences has announced through its subsidiary, Acenzia, a venture to launch new protein products with enhanced nutritional value into the global market, as part of a $5.4 million project with Protein Industries Canada. Acenzia is committing approximately $600,000 towards developing consumer-ready protein products, alongside Protein Industries Canada’s $2.3 million and $2.5 million from other partners. The collaborative effort aims to produce a modular, a ready-to-mix, and a ready-to-drink low-volume liquid protein.

See more insights into NVOS stock on TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskNovo Integrated Sciences Announces Major Funds Disbursement
TheFlyNovo Integrated Sciences files to sell 3.5M shares of common stock for holders
TipRanks Auto-Generated NewsdeskNovo Integrated Sciences Secures Leadership Until 2025
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Optimize your mobile reading experience. Download the TipRanks App today!